Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H15NO |
Molecular Weight | 237.2964 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1C2=C(CCC3=C1C=CC=C3)C=CC=C2
InChI
InChIKey=APBVLLORZMAWKI-UHFFFAOYSA-N
InChI=1S/C16H15NO/c17-16(18)15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-8,15H,9-10H2,(H2,17,18)
Molecular Formula | C16H15NO |
Molecular Weight | 237.2964 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Cyheptamide is anticonvulsant compound, developed by the Canadian company Ayerst Research Laboratories in the 1960s. Oral administration of compound at 14-25 mg/kg protected mice against the tonic phase of pentylenetetrazole convulsion and maximal electroshock seizure. Anticonvulsant activity of cyheptamide was confirmed in initial clinical studies, but the compound was not marketed.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:01 GMT 2023
by
admin
on
Fri Dec 15 15:02:01 GMT 2023
|
Record UNII |
6R22P8K61P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06868MIG
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
6R22P8K61P
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
230-570-8
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
C81469
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
7199-29-3
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL1868301
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
m1100
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000083759
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
23603
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
C002556
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
2191
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY | |||
|
DTXSID6046551
Created by
admin on Fri Dec 15 15:02:01 GMT 2023 , Edited by admin on Fri Dec 15 15:02:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |